Cannabinoid CB1 Receptors Activation and Coactivation With D2 Receptors Modulate GABAergic Neurotransmission in the Globus Pallidus and Increase Motor Asymmetry

被引:23
作者
Munoz-Arenas, Guadalupe [1 ,2 ]
Paz-Bermudez, Francisco [3 ]
Baez-Cordero, Ana [1 ,2 ]
Caballero-Floran, Rene [3 ]
Gonzalez-Hernandez, Brenda [4 ]
Floran, Benjamin [3 ]
Daniel Limon, I. [1 ,2 ]
机构
[1] Benemerita Univ Autonoma Puebla, Fac Ciencias Quim, Lab Neurofarmacol, Puebla 72570, Mexico
[2] Benemerita Univ Autonoma Puebla, Puebla 72570, Mexico
[3] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Fisiol Biofis & Neurociencias, Mexico City 07738, DF, Mexico
[4] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Mexico City, DF, Mexico
关键词
globus pallidus; cannabinoid CB1 receptor; dopaminergic D2 receptor; GABA uptake; GABA release; motor asymmetry; RAT BASAL GANGLIA; CONCURRENT STIMULATION; PARKINSONS-DISEASE; INDUCED DYSKINESIA; ANIMAL-MODEL; DOPAMINE; RELEASE; NEURONS; GABA; ANTAGONIST;
D O I
10.1002/syn.21796
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The cannabinoid CB1 (CB1R) and dopaminergic D2 (D2R) receptors modify GABAergic transmission in the globus pallidus. Although dopaminergic denervation produces changes in the expression and supersensitization of these receptors, the consequences of these changes on GABAergic neurotransmission are unknown. The aim of this study was to show the effects of CB1R and D2R activation and coactivation on the uptake and release of [H-3]GABA in the globus pallidus of hemiparkinsonian rats as well as their effects on motor behavior. The activation of CB1R blocked GABA uptake and decreased GABA release in the globus pallidus in the dopamine denervated side, whereas the co-activation of CB1R-D2R increased GABA release and had no effect on GABA uptake. A microinjection of the CB1R agonist ACEA into the globus pallidus ipsilaterally to a 6-OHDA lesion potentiated turning behavior that was induced by methamphetamine. However, a microinjection of the D2R agonist quinpirole did not modify this behavior, and a microinjection of a mixture of CB1R and D2R agonists significantly potentiated turning behavior. The behavioral effects produced after the activation of the CB1R and the co-activation of CB1R and D2R can be explained by increased GABAergic neurotransmission produced by a block of GABA uptake and an increase in the release of GABA in the globus pallidus, respectively. Synapse 69:103-114, 2015. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:103 / 114
页数:12
相关论文
共 53 条
[1]   Long-term changes of striatal dopamine D-2 receptors in patients with Parkinson's disease: A study with positron emission tomography and [C-11]Raclopride [J].
Antonini, A ;
Schwarz, J ;
Oertel, WH ;
Pogarell, O ;
Leenders, KL .
MOVEMENT DISORDERS, 1997, 12 (01) :33-38
[2]   Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease [J].
Blum, D ;
Torch, S ;
Lambeng, N ;
Nissou, MF ;
Benabid, AL ;
Sadoul, R ;
Verna, JM .
PROGRESS IN NEUROBIOLOGY, 2001, 65 (02) :135-172
[3]   Temporal Changes of CB1 Cannabinoid Receptor in the Basal Ganglia as a Possible Structure-Specific Plasticity Process in 6-OHDA Lesioned Rats [J].
Chaves-Kirsten, Gabriela P. ;
Mazucanti, Caio H. Y. ;
Real, Caroline C. ;
Souza, Bruna M. ;
Britto, Luiz R. G. ;
Torrao, Andrea S. .
PLOS ONE, 2013, 8 (10)
[4]   Concurrent activation of striatal direct and indirect pathways during action initiation [J].
Cui, Guohong ;
Jun, Sang Beom ;
Jin, Xin ;
Pham, Michael D. ;
Vogel, Steven S. ;
Lovinger, David M. ;
Costa, Rui M. .
NATURE, 2013, 494 (7436) :238-242
[5]   Modeling Parkinsn's disease in rats: An evaluation of 6-OHDA lesions of the nigrostriatal pathway [J].
Deumens, R ;
Blokland, A ;
Prickaerts, J .
EXPERIMENTAL NEUROLOGY, 2002, 175 (02) :303-317
[6]   Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease [J].
Di Marzo, V ;
Hill, MP ;
Bisogno, T ;
Crossman, AR ;
Brotchie, JM .
FASEB JOURNAL, 2000, 14 (10) :1432-1438
[7]   Effects on turning of microinjections into basal ganglia of D1 and D2 dopamine receptors agonists and the cannabinoid CB1 antagonist SR141716A in a rat Parkinson's model [J].
El Banoua, F ;
Caraballo, I ;
Flores, JA ;
Galan-Rodriguez, B ;
Fernandez-Espejo, E .
NEUROBIOLOGY OF DISEASE, 2004, 16 (02) :377-385
[8]   Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism [J].
Fernandez-Espejo, E ;
Caraballo, I ;
de Fonseca, FR ;
El Banoua, F ;
Ferrer, B ;
Flores, JA ;
Galan-Rodriguez, B .
NEUROBIOLOGY OF DISEASE, 2005, 18 (03) :591-601
[9]   Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias [J].
Ferrer, B ;
Asbrock, N ;
Kathuria, S ;
Piomelli, D ;
Giuffrida, A .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2003, 18 (06) :1607-1614
[10]   Dopamine D4 receptors inhibit depolarization-induced [3H]GABA release in the rat subthalamic nucleus [J].
Floran, B ;
Floran, L ;
Erlij, D ;
Aceves, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 498 (1-3) :97-102